Clinical Trial: Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07682454) titled 'Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin' on June 26.

Brief Summary: This is a single-arm, open-label, single-center, first-in-human feasibility study evaluating parenchymal blood volume (PBV) imaging as a tool to dynamically assess perfusional changes in hepatocellular carcinoma (HCC) potentiated by intra-arterial administration of nitroglycerin.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Hepatocellular Carcinoma (HCC) Liver Cancer, Adult

Intervention: PROCEDURE: Parenchymal Blood Volume (PBV) Imaging

Undergo imaging

DRUG: Nitr...